TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Drug Overdose/drug therapy
KW - Humans
KW - Opiate Overdose
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - MOUD
KW - Opioid
KW - buprenorphine
KW - Methadone
KW - providers
KW - qualitative
AU - N. Paul
AU - A. J. Kennedy
AU - S. Taubenberger
AU - J. C. Chang
AU - K. Hacker
A1 - 
AB - BACKGROUND: Medication for Opioid Use Disorder (MOUD) has been shown to be a safe, cost-effective intervention that successfully lowers risk of opioid overdose. However, access to and use of MOUD has been limited. Our objective was to explore attitudes, opinions, and beliefs regarding MOUD among healthcare and social service providers in a community highly impacted by the opioid overdose epidemic. METHODS: As part of a larger ethnographic study examining neighborhoods in Allegheny County, PA, with the highest opioid overdose death rates, semi-structured qualitative in-person and telephone interviews were conducted with forty-five providers treating persons with opioid use disorders in these communities. An open coding approach was used to code interview transcripts followed by thematic analysis. RESULTS: Three major themes were identified related to MOUD from the perspectives of our provider participants. Within a variety of health and substance use service roles and settings, provider reflections revealed: (1) different opinions about MOUD as a transition to abstinence or as a long-term treatment; (2) perceived lack of uniformity and dissemination of accurate information of MOUD care, permitting differences in care, and (3) observed barriers to entry and navigation of MOUD, including referrals as a "word-of-mouth insider system" and challenges of getting patients MOUD services when they need it. CONCLUSIONS: Even in communities hard hit by the opioid overdose epidemic, healthcare providers' disagreement about the standard of care for MOUD can be a relevant obstacle. These insights can inform efforts to improve MOUD treatment and access for people with opioid use disorders.
AD - Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Division of General Internal Medicine, University of Washington School of Medicine, Seattle, Washington, USA.; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.; Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USA.
BT - Substance abuse
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 1
CY - United States
DO - 10.1080/08897077.2021.2007518
IS - 1
JF - Substance abuse
LA - eng
M1 - Journal Article
N2 - BACKGROUND: Medication for Opioid Use Disorder (MOUD) has been shown to be a safe, cost-effective intervention that successfully lowers risk of opioid overdose. However, access to and use of MOUD has been limited. Our objective was to explore attitudes, opinions, and beliefs regarding MOUD among healthcare and social service providers in a community highly impacted by the opioid overdose epidemic. METHODS: As part of a larger ethnographic study examining neighborhoods in Allegheny County, PA, with the highest opioid overdose death rates, semi-structured qualitative in-person and telephone interviews were conducted with forty-five providers treating persons with opioid use disorders in these communities. An open coding approach was used to code interview transcripts followed by thematic analysis. RESULTS: Three major themes were identified related to MOUD from the perspectives of our provider participants. Within a variety of health and substance use service roles and settings, provider reflections revealed: (1) different opinions about MOUD as a transition to abstinence or as a long-term treatment; (2) perceived lack of uniformity and dissemination of accurate information of MOUD care, permitting differences in care, and (3) observed barriers to entry and navigation of MOUD, including referrals as a "word-of-mouth insider system" and challenges of getting patients MOUD services when they need it. CONCLUSIONS: Even in communities hard hit by the opioid overdose epidemic, healthcare providers' disagreement about the standard of care for MOUD can be a relevant obstacle. These insights can inform efforts to improve MOUD treatment and access for people with opioid use disorders.
PP - United States
PY - 2022
SN - 1547-0164; 0889-7077
SP - 742
EP - 748
EP - 
T1 - Provider perceptions of medication for opioid used disorder (MOUD): A qualitative study in communities with high opioid overdose death rates
T2 - Substance abuse
TI - Provider perceptions of medication for opioid used disorder (MOUD): A qualitative study in communities with high opioid overdose death rates
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 35100094
U3 - 10.1080/08897077.2021.2007518
VL - 43
VO - 1547-0164; 0889-7077
Y1 - 2022
ER -